• Je něco špatně v tomto záznamu ?

Hypoxia Downregulates MAPK/ERK but Not STAT3 Signaling in ROS-Dependent and HIF-1-Independent Manners in Mouse Embryonic Stem Cells

J. Kučera, J. Netušilová, S. Sladeček, M. Lánová, O. Vašíček, K. Štefková, J. Navrátilová, L. Kubala, J. Pacherník,

. 2017 ; 2017 (-) : 4386947. [pub] 20170727

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18024728

Hypoxia is involved in the regulation of stem cell fate, and hypoxia-inducible factor 1 (HIF-1) is the master regulator of hypoxic response. Here, we focus on the effect of hypoxia on intracellular signaling pathways responsible for mouse embryonic stem (ES) cell maintenance. We employed wild-type and HIF-1α-deficient ES cells to investigate hypoxic response in the ERK, Akt, and STAT3 pathways. Cultivation in 1% O2 for 24 h resulted in the strong dephosphorylation of ERK and its upstream kinases and to a lesser extent of Akt in an HIF-1-independent manner, while STAT3 phosphorylation remained unaffected. Downregulation of ERK could not be mimicked either by pharmacologically induced hypoxia or by the overexpression. Dual-specificity phosphatases (DUSP) 1, 5, and 6 are hypoxia-sensitive MAPK-specific phosphatases involved in ERK downregulation, and protein phosphatase 2A (PP2A) regulates both ERK and Akt. However, combining multiple approaches, we revealed the limited significance of DUSPs and PP2A in the hypoxia-mediated attenuation of ERK signaling. Interestingly, we observed a decreased reactive oxygen species (ROS) level in hypoxia and a similar phosphorylation pattern for ERK when the cells were supplemented with glutathione. Therefore, we suggest a potential role for the ROS-dependent attenuation of ERK signaling in hypoxia, without the involvement of HIF-1.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18024728
003      
CZ-PrNML
005      
20180718105449.0
007      
ta
008      
180709s2017 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1155/2017/4386947 $2 doi
035    __
$a (PubMed)28819544
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kučera, Jan $u Institute of Experimental Biology, Faculty of Science, Masaryk University, Kotlářská 267/2, 61137 Brno, Czech Republic.
245    10
$a Hypoxia Downregulates MAPK/ERK but Not STAT3 Signaling in ROS-Dependent and HIF-1-Independent Manners in Mouse Embryonic Stem Cells / $c J. Kučera, J. Netušilová, S. Sladeček, M. Lánová, O. Vašíček, K. Štefková, J. Navrátilová, L. Kubala, J. Pacherník,
520    9_
$a Hypoxia is involved in the regulation of stem cell fate, and hypoxia-inducible factor 1 (HIF-1) is the master regulator of hypoxic response. Here, we focus on the effect of hypoxia on intracellular signaling pathways responsible for mouse embryonic stem (ES) cell maintenance. We employed wild-type and HIF-1α-deficient ES cells to investigate hypoxic response in the ERK, Akt, and STAT3 pathways. Cultivation in 1% O2 for 24 h resulted in the strong dephosphorylation of ERK and its upstream kinases and to a lesser extent of Akt in an HIF-1-independent manner, while STAT3 phosphorylation remained unaffected. Downregulation of ERK could not be mimicked either by pharmacologically induced hypoxia or by the overexpression. Dual-specificity phosphatases (DUSP) 1, 5, and 6 are hypoxia-sensitive MAPK-specific phosphatases involved in ERK downregulation, and protein phosphatase 2A (PP2A) regulates both ERK and Akt. However, combining multiple approaches, we revealed the limited significance of DUSPs and PP2A in the hypoxia-mediated attenuation of ERK signaling. Interestingly, we observed a decreased reactive oxygen species (ROS) level in hypoxia and a similar phosphorylation pattern for ERK when the cells were supplemented with glutathione. Therefore, we suggest a potential role for the ROS-dependent attenuation of ERK signaling in hypoxia, without the involvement of HIF-1.
650    _2
$a zvířata $7 D000818
650    _2
$a down regulace $7 D015536
650    _2
$a faktor 1 indukovatelný hypoxií - podjednotka alfa $x metabolismus $7 D051795
650    _2
$a myši $7 D051379
650    _2
$a mitogenem aktivované proteinkinasy kinas $x metabolismus $7 D020929
650    _2
$a myší embryonální kmenové buňky $x metabolismus $7 D000066450
650    _2
$a reaktivní formy kyslíku $x metabolismus $7 D017382
650    _2
$a signální transdukce $7 D015398
655    _2
$a časopisecké články $7 D016428
700    1_
$a Netušilová, Julie $u Institute of Experimental Biology, Faculty of Science, Masaryk University, Kotlářská 267/2, 61137 Brno, Czech Republic.
700    1_
$a Sladeček, Stanislava $u Institute of Experimental Biology, Faculty of Science, Masaryk University, Kotlářská 267/2, 61137 Brno, Czech Republic.
700    1_
$a Lánová, Martina $u Institute of Experimental Biology, Faculty of Science, Masaryk University, Kotlářská 267/2, 61137 Brno, Czech Republic.
700    1_
$a Vašíček, Ondřej $u Institute of Biophysics, Academy of Sciences of the Czech Republic, Královopolská 2590/135, 61200 Brno, Czech Republic. International Clinical Research Center, Centre of Biomolecular and Cellular Engineering, St. Anne's University Hospital, Pekařská 53, 65691 Brno, Czech Republic.
700    1_
$a Štefková, Kateřina $u Institute of Experimental Biology, Faculty of Science, Masaryk University, Kotlářská 267/2, 61137 Brno, Czech Republic.
700    1_
$a Navrátilová, Jarmila $u Institute of Experimental Biology, Faculty of Science, Masaryk University, Kotlářská 267/2, 61137 Brno, Czech Republic.
700    1_
$a Kubala, Lukáš $u Institute of Biophysics, Academy of Sciences of the Czech Republic, Královopolská 2590/135, 61200 Brno, Czech Republic. International Clinical Research Center, Centre of Biomolecular and Cellular Engineering, St. Anne's University Hospital, Pekařská 53, 65691 Brno, Czech Republic.
700    1_
$a Pacherník, Jiří $u Institute of Experimental Biology, Faculty of Science, Masaryk University, Kotlářská 267/2, 61137 Brno, Czech Republic. International Clinical Research Center, Centre of Biomolecular and Cellular Engineering, St. Anne's University Hospital, Pekařská 53, 65691 Brno, Czech Republic.
773    0_
$w MED00180520 $t Oxidative medicine and cellular longevity $x 1942-0994 $g Roč. 2017, č. - (2017), s. 4386947
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28819544 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180709 $b ABA008
991    __
$a 20180718105749 $b ABA008
999    __
$a ok $b bmc $g 1316859 $s 1021649
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 2017 $c - $d 4386947 $e 20170727 $i 1942-0994 $m Oxidative medicine and cellular longevity $n Oxid Med Cell Longev $x MED00180520
LZP    __
$a Pubmed-20180709

Najít záznam

Citační ukazatele

Možnosti archivace